<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1913-1263'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/profile/">Profile</a>
<span>AML Comprehensive Panel </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">AML Comprehensive Panel </h1>
<div class="post-text">
<p>Acute Myeloid Leukemia (AML) is a complex and aggressive blood cancer characterized by the rapid growth of abnormal white blood cells. The AML Comprehensive Panel is an advanced diagnostic test designed to provide in-depth information about the genetic and cellular characteristics of AML. This panel combines flow cytometry, karyotyping, Fluorescence In Situ Hybridization (FISH) for three markers, and testing for mutations in FLT3, NPM1, and CEBPA genes. Flow cytometry measures the physical and chemical characteristics of cells, karyotyping analyzes the number and structure of chromosomes, FISH detects specific DNA sequences, and the gene tests identify mutations that are crucial in diagnosing, stratifying risk, and managing AML.</p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Profile Name</th>
			<td scope="col">AML Comprehensive Panel: Flowcytometry - Acute Leukemia Comprehensive Panel + Karyotyping + FISH for Three Markers + FLT3 + NPM1 + CEBPA </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td> Bone Marrow / Blood</td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No fasting is required, but it’s important to inform your doctor about any medications you are taking.</td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>12 days</td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>₹ 34900 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3">What is the importance of the AML Comprehensive Panel?</h2>
<p>The AML Comprehensive Panel is critical for the diagnosis and risk stratification of AML. It provides detailed
    information on cellular characteristics, chromosomal abnormalities, and specific gene mutations, helping doctors
    formulate a personalized treatment plan for patients.</p>
<h2 class="test-h2 mt-3">Do I need to fast before taking the AML Comprehensive Panel?</h2>
<p>No, there is no need to fast before undergoing the AML Comprehensive Panel.</p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->

<h2 class="test-h2 mt-3">What kind of information does the AML Comprehensive Panel provide?</h2>
<p>This panel provides a wealth of information including cellular characteristics through flow cytometry, chromosomal
    number and structure through karyotyping, specific DNA sequences through FISH, and mutations in the FLT3, NPM1, and
    CEBPA genes.</p>
<h2 class="test-h2 mt-3">How often should this test be performed?</h2>
<p>The frequency of the test depends on the doctor’s recommendations and the patient's condition. It's typically
    performed at diagnosis and may be repeated to monitor response to treatment or check for recurrence.</p>
<h2 class="test-h2 mt-3">Are there any risks associated with this test?</h2>
<p>The risks are minimal and are mainly related to the collection of the blood or bone marrow sample. These may include
    discomfort, bruising, and, in rare cases, infection.</p>
<h2 class="test-h2 mt-3">What do normal values indicate?</h2>
<p>Normal values indicate the absence of the AML-related abnormalities. However, results can vary, and it is essential
    to have them interpreted by your doctor.</p>
<h2 class="test-h2 mt-3">Are there precautions to be taken before or after undergoing the test?</h2>
<p>No specific precautions are required, but it is essential to inform your doctor about any medications or supplements
    you are taking.</p>
<h2 class="test-h2 mt-3">Which doctor should I consult if the test values are abnormal?</h2>
<p>If the test values are abnormal, it is advisable to consult a hematologist or oncologist.</p>
<h2 class="test-h2 mt-3">Can the AML Comprehensive Panel predict how the disease will progress?</h2>
<p>Yes, by identifying specific genetic mutations and chromosomal abnormalities, the AML Comprehensive Panel can help in
    predicting the course of the disease and the likely response to therapy.</p>
<h2 class="test-h2 mt-3">How can this panel help in treatment decisions?</h2>
<p>By providing detailed information on the genetic makeup of the leukemia cells, this panel helps doctors to choose the
    most effective treatment strategies, which can include chemotherapy, targeted therapy, or stem cell transplant.</p>
<h2 class="test-h2 mt-3">What factors can affect the results of this test?</h2>
<p><b>Modifiable Factors:</b> Some medications and treatments can affect the levels.</p>
<P><b>Non-modifiable Factors:</b> Genetic makeup and age can also influence the levels.</P>
<h2 class="test-h2 mt-3">What is the FLT3 mutation and why is it important?</h2>
<p>FLT3 is a gene often mutated in AML, and it plays a role in the growth of cancer cells. Identifying FLT3 mutations
    helps in predicting prognosis and can guide treatment decisions.</p>
<h2 class="test-h2 mt-3">What are NPM1 and CEBPA genes?</h2>
<p>NPM1 and CEBPA are genes that can be mutated in AML. Like FLT3, mutations in these genes are essential for prognosis
    and can be targets for specific therapies.</p>
<h2 class="test-h2 mt-3">Why is it important to identify chromosomal abnormalities in AML?</h2>
<p>Chromosomal abnormalities in AML are often associated with how aggressive the disease is and how it responds to
    treatment. Identifying these abnormalities helps in risk stratification and treatment planning.</p>
<h2 class="test-h2 mt-3">Can this test be used to monitor the effectiveness of treatment?</h2>
<p>Yes, the AML Comprehensive Panel can be used to monitor the effectiveness of treatment by tracking changes in
    cellular characteristics and genetic markers over time.</p>
<p>The AML Comprehensive Panel is an essential tool for diagnosing and managing Acute Myeloid Leukemia. This panel
    combines several diagnostic tests to provide a comprehensive overview of the genetic and cellular characteristics of
    the disease. It is crucial for patients diagnosed with AML to discuss the results of this panel with their doctor to
    understand the implications for treatment and prognosis. This information is essential in developing a personalized
    treatment plan tailored to the specific characteristics of the patient’s disease. Regular monitoring through the AML
    Comprehensive Panel can also be vital in assessing the effectiveness of treatment and making necessary adjustments.
</p>
 
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>